Abstract
INTRODUCTION
The total patient population for each clinic was estimated from GP profile records provided by 119 the Association of Public Health Observatories (APHO), and the cohort ages were assumed uni-120 formly distributed. The total population age 0-19 for all of Ealing was estimated at 95,775. given on or after their first birthday.
is the total population size which is the summation of all children and adolescents in all these 135 states at a given time period (N=M+S+E+I+R+V).
137
The differential equations of the system are given below. The number in subscript represents the 138 individual cohorts, where 0 is age 0 and 1 is age 1-3 etc. There are four sets of equations for the 139 four cohorts modeled. In the first set of equations (Eq.1a-e), new children are added to the popu-140 lation with a rate of µ. Initially, a child is protected by the maternal immunity for a period of (1/ 141 λ b ) year where λ b is the maternal immunity loss rate. This is also the rate they enter the suscepti- 
Parameterization

178
Descriptions of the parameters, their values and the references are shown in Table 1 . The esti-179 mated duration of maternal immunity varies from 3 to 6 months (10-13). We use 4 months as 180 advocated by Bjornstad et al. [14] . phase infection transmitted through social contacts, which can also be seen in Figure 6 where the 192 data for UK is shown.
194
When a child receives a dose of measles vaccine, it takes on average 10 days for the vaccine to
195
give protection [19] . Thus, the inoculated immunity rate σ is 0. for cohort 0). Measles incidence is modeled 5 years into the future for both of these alternatives,
223
and compared to the status quo where the vaccination coverage is kept identical to the most re-224 cent data (MMR1 from age group 1-3 and MMR2 from age group 4-6). In Figure 8 we show the daily measles incidence for the four cohorts at year 2011 and 2012. George E. P. Box [24] observed that "essentially, all models are wrong, but some are useful".
317
Modeling can advise the development of public health policy, but given the uncertainties associ-318 ated with public health data, it is essential that the assumptions built into such models and the 319 models themselves be fully transparent. Perhaps the greatest strength of STEM is not the use of effects on the wider healthcare system, e.g., reductions in emergency admissions and attribution of costs of intervention and disease. Ultimately, the goal is to allow non-technical users to build 335 models of infectious disease, upload data and evaluate interventions strategies for patient benefit. [2013] [2014] [2015] [2016] [2017] for the two scenarios studied as well as the status quo case.
